William P Forbes Insider Trading $SLXP SALIX PHARMACEUTICALS LTD
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William P Forbes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William P Forbes. William P Forbes is EVP Research&Devel & CDO in SALIX PHARMACEUTICALS LTD ($SLXP) and V.P. Research& Devel & CDO in SALIX PHARMACEUTICALS LTD ($SLXP).
William P Forbes in SALIX PHARMACEUTICALS LTD
Trading Symbol: SLXPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William P Forbes: EVP Research&Devel & CDO, V.P. Research& Devel & CDO
Holdings: 58,143 shares
Latest Transaction: Jul 11 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of William P Forbes in SALIX PHARMACEUTICALS LTD
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 11 2011 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | EVP Research&Devel ... | Sell | S | 39.60 | 13,000 | 514,764 | 58,143 | 71.1 K to 58.1 K (-18.27 %) |
Jul 06 2011 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | EVP Research&Devel ... | Payment of Exercise | F | 39.83 | 9,212 | 366,914 | 71,143 | 80.4 K to 71.1 K (-11.46 %) |
May 18 2011 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | EVP Research&Devel ... | Option Exercise | M | 17.53 | 20,000 | 350,600 | 60,000 | |
May 18 2011 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | EVP Research&Devel ... | Sell | S | 40.35 | 20,000 | 806,986 | 80,355 | 100.4 K to 80.4 K (-19.93 %) |
May 18 2011 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | EVP Research&Devel ... | Buy | M | 17.53 | 20,000 | 350,600 | 100,355 | 80.4 K to 100.4 K (+24.89 %) |
May 04 2011 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Grant | A | 0.00 | 22,698 | 0 | 80,355 | 57.7 K to 80.4 K (+39.37 %) |
Nov 12 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Option Exercise | M | 17.53 | 10,000 | 175,300 | 80,000 | |
Nov 12 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Sell | S | 40.01 | 10,000 | 400,053 | 57,657 | 67.7 K to 57.7 K (-14.78 %) |
Nov 12 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Buy | M | 17.53 | 10,000 | 175,300 | 67,657 | 57.7 K to 67.7 K (+17.34 %) |
Sep 16 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Sell | S | 40.50 | 10,695 | 433,108 | 57,657 | 68.4 K to 57.7 K (-15.65 %) |
Jul 21 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Grant | A | 0.00 | 15,055 | 0 | 68,352 | 53.3 K to 68.4 K (+28.25 %) |
Jul 06 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Payment of Exercise | F | 39.03 | 7,586 | 296,082 | 53,297 | 60.9 K to 53.3 K (-12.46 %) |
Apr 16 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Option Exercise | M | 17.53 | 10,000 | 175,300 | 90,000 | |
Apr 16 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Sell | S | 40.03 | 10,000 | 400,251 | 60,883 | 70.9 K to 60.9 K (-14.11 %) |
Apr 16 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Buy | M | 17.53 | 10,000 | 175,300 | 70,883 | 60.9 K to 70.9 K (+16.42 %) |
Apr 05 2010 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Sell | S | 38.00 | 1,879 | 71,402 | 60,883 | 62.8 K to 60.9 K (-2.99 %) |
Dec 28 2009 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Sell | S | 25.00 | 5,000 | 125,000 | 62,762 | 67.8 K to 62.8 K (-7.38 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Grant | A | 0.00 | 21,890 | 0 | 67,762 | 45.9 K to 67.8 K (+47.72 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Payment of Exercise | F | 9.87 | 5,141 | 50,742 | 45,872 | 51 K to 45.9 K (-10.08 %) |
Jul 03 2008 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Grant | A | 0.00 | 27,000 | 0 | 51,013 | 24 K to 51 K (+112.44 %) |
Jul 03 2008 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Payment of Exercise | F | 7.03 | 2,219 | 15,600 | 24,013 | 26.2 K to 24 K (-8.46 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Sell | S | 12.31 | 100 | 1,231 | 26,232 | 26.3 K to 26.2 K (-0.38 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Sell | S | 12.33 | 1,013 | 12,490 | 26,332 | 27.3 K to 26.3 K (-3.70 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Grant | A | 0.00 | 13,845 | 0 | 27,345 | 13.5 K to 27.3 K (+102.56 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Grant | A | 0.00 | 13,500 | 0 | 13,500 | 0 to 13.5 K |
Page: 1